A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...

FDA fast track status was supported by two monotherapy responses in MSI-H colorectal cancer, including one complete response and one partial response, both durable beyond 80 weeks. Suplexa uses ...

Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...

A cancer diagnosis is never welcome news. But for certain types of cancers, a doctor’s confirmation can be a lifesaver. That’s especially true with colorectal—or colon—cancer (CRC): When caught early, ...

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...

Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course of post-surgery radiotherapy is just as safe and effective as the ...

Colorectal cancer is officially the leading cause of cancer-related death among younger men, according to a January report by the American Cancer Society. It is also the second leading cause for women ...

A newly identified colon cancer gene may drive the disease by making the environment in the vicinity of tumors more hospitable to them, researchers say. The gene, which appears to speed tumor growth ...

“While most people who develop diabetes will not have cancer, this link is seen in a significant proportion of pancreatic ...